The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines

BACKGROUND: Falsely labelled, falsified (counterfeit) medicines (FFCm’s) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm’s is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Health-Care (EDQM) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Anđelković, Marija, Björnsson, Einar, De Bono, Virgilio, Dikić, Nenad, Devue, Katleen, Ferlin, Daniel, Hanževački, Miroslav, Jónsdóttir, Freyja, Shakaryan, Mkrtich, Walser, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477164/
https://www.ncbi.nlm.nih.gov/pubmed/28633634
http://dx.doi.org/10.1186/s12913-017-2235-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477164/
https://www.ncbi.nlm.nih.gov/pubmed/28633634
http://dx.doi.org/10.1186/s12913-017-2235-y

Ejemplares similares